• 28-May-2021 to 28-Jun-2021 (EST)
  • Clinical Development
  • Gaithersburg, MD, USA
  • Full Time - Exempt

If you find science, speed, and success exhilarating, you have come to the right place.

Novavax, Inc. (Nasdaq: NVAX) is a biotechnology company that promotes improved health globally through the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases.  Novavax is currently conducting multiple late-stage clinical trials for NVX-CoV2373, our vaccine candidate against the virus that causes COVID-19, and has recently reported exciting and highly encouraging initial efficacy results. NanoFlu, our quadrivalent influenza nanoparticle vaccine, met all primary objectives in its pivotal Phase 3 clinical trial in older adults. Both candidate vaccines incorporate Novavax' proprietary saponin-based Matrix-M adjuvant to enhance the immune response and stimulate high levels of neutralizing antibodies. Novavax is a leading innovator of recombinant vaccines. Our proprietary technology platform leverages the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles in order to address urgent global health needs.

Novavax, Inc. is headquartered in Gaithersburg, Maryland with additional facilities in Uppsala, Sweden and Bohumil, Czech Republic.

We are seeking a Principal Risk Management Scientist, who will be responsible for providing pharmacovigilance risk management functional area expertise and support to project teams assigned to developmental and/or marketed products. This includes participating in safety review activities, managing the cross-functional assessment of the benefit-risk profile, and communication of safety information to internal and external stakeholders. This position will support all aspects of the Novavax risk management system. This position will report to the Sr. Director, Pharmacovigilance Risk Management.

Responsibilities include but are not limited to:

  • Participates in the development and execution of risk management plans (RMPs) globally
  • Ensures the implementation of risk management commitments globally according to RMPs
  • Provides risk management expertise (e.g., regulations, processes, principles, methods, tools, best practices) to cross-functional teams
  • Measures compliance with risk management post-marketing commitments and provides status reports
  • Supports inspections and audits related to RMPs and risk management commitments
  • Manages risk management projects, including project planning, budgets, vendors, communication, etc.
  • Monitors/track implementation of additional PV (e.g., PASS, PAES) and/or additional risk minimization activities using designated tracking tools
  • Schedules and facilitates cross-functional risk management team meetings and communications, including safety, regulatory, clinical, medical affairs, etc.
  • Prepares and delivers training programs on implementation of risk management activities
  • Liaises with Qualified Person for Pharmacovigilance (QPPV) and/or Local Safety Officers to implement risk management activities locally, as needed
  • Escalates risk management issues to Safety Leadership, as needed

Minimum requirements:

  • PharmD/PhD in relevant scientific discipline with 5+ years' experience in Safety and Pharmacovigilance working on global clinical trials in a biotechnology or pharmaceutical company
  • Masters with 10+ years' experience or Bachelor's degree with 13+ years' experience
  • PharmD/MSc/PhD in scientific field preferred
  • Experience reviewing cumulative safety data with ability to interpret, synthesize and communicate complex safety information
  • Experience in the preparation and authorizing of individual and aggregate safety reports as well as other clinical/regulatory documents
  • Working knowledge of MedDRA

Additional desirable skills:

  • Experience in global pharmaceutical/biotechnology company, with special reference to vaccines and/or immunotherapeutic, and preparation of risk management plans, aggregate reports and other company core safety documents
  • Proven experience working in/leading (safety &/or scientific) pre- and post-authorization risk management programs
  • Strong attention to detail and persistence in following tasks through to completion
  • Proficiency with standard office software (Microsoft Office)
  • Good organizational and prioritization skills
  • Good interpersonal skills (i.e. team player)
  • Ability to work independently
  • Flexibility and ability to adapt and learn quickly
  • Ability to work under pressure and to tight deadlines
  • Excellent communication and presentation skills in English (both written and spoken)

Novavax is headquartered in Gaithersburg, Maryland with additional facilities in Uppsala, Sweden and Bohumil, Czech Republic. Novavax is traded on the Nasdaq Stock Market under the symbol NVAX and is dedicated to developing novel vaccines to address infectious disease.

Novavax offers a base salary, annual bonus, equity grants, professional career development/growth opportunities, and a comprehensive benefits package including medical, dental, vision, Rx, STD, LTD, Life, Optional Life, 401(k) plan.

Equal Opportunity Employer/Veterans/Disabled

Novavax is an equal employment opportunity employer. Employment and advancement opportunities are available to all individuals on an at-will basis, regardless of their race, color, national origin, religion, ancestry, citizenship status, military or veteran status, sex, sexual orientation, gender identity or expression, age, marital status, family responsibilities, pregnancy, disability, genetic information, protective hairstyle, or any other characteristic protected by applicable federal, state, or local law. #LI-Remote #LI-GS1


  • Apply Now

    with our quick 3 minute Application!

  • * Fields Are Required

    What is your full name?

    How can we contact you?

  • Sign Up For Job Alerts!

  • Share This Page
  • Facebook Twitter LinkedIn Email
Novavax About Us Our Pipeline Science and Technology Resources Careers For Investors Corporate Governance Stock Information Events SEC Filings Analyst Coverage Investor Relations Contact Annual Report Investor Presentation News COVID-19 Candidate Updates Press Releases Novavax in the News Join the Press Release List Press Center Contact Us YouTube LinkedIn Twitter Privacy Policy Terms and Conditions Pay Transparency Nondiscrimination Provision Purchase Order Terms and Conditions
for investors news careers contact us covid19 logo about us our pipeline science resources